Seasonal mercury exposure and oxidant-antioxidant status of James Bay sport fishermen

Metabolism: Clinical and Experimental

Volumn 57, Issue 5, 2008, Pages 630-636

  Bélanger, Marie Claire ^a,b   Mirault, Marc Edouard ^a,b   Dewailly, Eric ^a,b   Plante, Michel ^a,b,c   Berthiaume, Line ^a,b   Noël, Micheline ^a,b   Julien, Pierre ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c HYDRO QUÉBEC   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; BIOLOGICAL MARKER; FATTY ACID; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MERCURY; OMEGA 3 FATTY ACID; SELENIUM; UBIDECARENONE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; EXPOSURE; FISHERMAN; FOOD INTAKE; HEALTH STATUS; HUMAN; LIPID OXIDATION; MALE; PRIORITY JOURNAL; SEASONAL VARIATION;

ADULT; ANTIOXIDANTS; FISHERIES; HUMANS; LIPOPROTEINS, LDL; MALE; METHYLMERCURY COMPOUNDS; MIDDLE AGED; OCCUPATIONAL EXPOSURE; SEASONS; TOCOPHEROLS; UBIQUINONE;

EID: 42949115808     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.12.006     Document Type: Article

References (59)

1. Clarkson T.W., and Magos L. The toxicology of mercury and its chemical compounds. Crit Rev Toxicol 36 (2006) 609-662
2. Clarkson T.W., Magos L., and Myers G.J. The toxicology of mercury-current exposures and clinical manifestations. N Engl J Med 349 (2003) 1731-1737
3. Guallar E., Sanz-Gallardo M.I., van't Veer P., Bode P., Aro A., Gomez-Aracena J., et al. Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med 347 (2002) 1747-1754
4. Yoshizawa K., Rimm E.B., Morris J.S., Spate V.L., Hsieh C.C., Spiegelman D., et al. Mercury and the risk of coronary heart disease in men. N Engl J Med 347 (2002) 1755-1760
5. Salonen J.T., Seppanen K., Nyyssonen K., Korpela H., Kauhanen J., Kantola M., et al. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation 91 (1995) 645-655
6. Salonen J.T., Seppanen K., Lakka T.A., Salonen R., and Kaplan G.A. Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis 148 (2000) 265-273
7. Chisolm G.M., and Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med 28 (2000) 1815-1826
8. Stocker R., and Keaney Jr. J.F. Role of oxidative modifications in atherosclerosis. Physiol Rev 84 (2004) 1381-1478
9. Seppanen K., Soininen P., Salonen J.T., Lotjonen S., and Laatikainen R. Does mercury promote lipid peroxidation? An in vitro study concerning mercury, copper, and iron in peroxidation of low-density lipoprotein. Biol Trace Elem Res 101 (2004) 117-132
10. Salonen J.T., Alfthan G., Huttunen J.K., Pikkarainen J., and Puska P. Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet 2 (1982) 175-179
11. Salonen J.T., Salonen R., Seppanen K., Kantola M., Parviainen M., Alfthan G., et al. Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in Eastern Finnish men. Atherosclerosis 70 (1988) 155-160
12. Muckle G., Ayotte P., Dewailly E., Jacobson S.W., and Jacobson J.L. Determinants of polychlorinated biphenyls and methylmercury exposure in Inuit women of childbearing age. Environ Health Perspect 109 (2001) 957-963
13. Dewailly E., Blanchet C., Lemieux S., Sauve L., Gingras S., Ayotte P., et al. n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik. Am J Clin Nutr 74 (2001) 464-473
14. Belanger M.C., Dewailly E., Berthiaume L., Noel M., Bergeron J., Mirault M.E., et al. Dietary contaminants and oxidative stress in Inuit of Nunavik. Metabolism 55 (2006) 989-995
15. LeBel C.P., Ali S.F., McKee M., and Bondy S.C. Organometal-induced increases in oxygen reactive species: the potential of 2¢,7¢-dichlorofluorescin diacetate as an index of neurotoxic damage. Toxicol Appl Pharmacol 104 (1990) 17-24
16. LeBel C.P., Ali S.F., and Bondy S.C. Deferoxamine inhibits methyl mercury-induced increases in reactive oxygen species formation in rat brain. Toxicol Appl Pharmacol 112 (1992) 161-165
17. Lund B.O., Miller D.M., and Woods J.S. Studies on Hg(II)-induced H2O2 formation and oxidative stress in vivo and in vitro in rat kidney mitochondria. Biochem Pharmacol 45 (1993) 2017-2024
18. Yee S., and Choi B.H. Methylmercury poisoning induces oxidative stress in the mouse brain. Exp Mol Pathol 60 (1994) 188-196
19. Sarafian T., and Verity M.A. Oxidative mechanisms underlying methyl mercury neurotoxicity. Int J Dev Neurosci 9 (1991) 147-153
20. Farant J.P., Brissette D., Moncion L., Bigras L., and Chartrand A. Improved cold-vapor atomic absorption technique for the microdetermination of total and inorganic mercury in biological samples. J Anal Toxicol 5 (1981) 47-51
21. Labat L., Dehon B., and Lhermitte M. Rapid and simple determination of selenium in blood serum by inductively coupled plasma-mass spectrometry (ICP-MS). Anal Bioanal Chem 3 (2003) 3
22. Ordovas J.M. Fast ultracentrifugation methods for the separation of plasma lipoproteins. Methods Mol Biol 110 (1998) 93-103
23. Connelly P.W., Poapst M., Davignon J., Lussier-Cacan S., Reeder B., Lessard R., et al. Reference values of plasma apolipoproteins A-I and B, and association with nonlipid risk factors in the populations of two Canadian provinces: Quebec and Saskatchewan. Canadian Heart Health Surveys Research Group. Can J Cardiol 15 (1999) 409-418
24. Shaikh N.A., and Downar E. Time course of changes in porcine myocardial phospholipid levels during ischemia. A reassessment of the lysolipid hypothesis. Circ Res 49 (1981) 316-325
25. Lepage G., and Roy C.C. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27 (1986) 114-120
26. Holvoet P., Mertens A., Verhamme P., Bogaerts K., Beyens G., Verhaeghe R., et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 21 (2001) 844-848
27. Anderson M.E. Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol 113 (1985) 548-555
28. Fortin L.J., and Genest Jr. J. Measurement of homocyst(e)ine in the prediction of arteriosclerosis. Clin Biochem 28 (1995) 155-162
29. Finckh B., Kontush A., Commentz J., Hubner C., Burdelski M., and Kohlschutter A. High-performance liquid chromatography-coulometric electrochemical detection of ubiquinol 10, ubiquinone 10, carotenoids, and tocopherols in neonatal plasma. Methods Enzymol 299 (1999) 341-348
30. Yamashita S., and Yamamoto Y. Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress. Anal Biochem 250 (1997) 66-73
31. Menke T., Niklowitz P., Adam S., Weber M., Schluter B., and Andler W. Simultaneous detection of ubiquinol-10, ubiquinone-10, and tocopherols in human plasma microsamples and macrosamples as a marker of oxidative damage in neonates and infants. Anal Biochem 282 (2000) 209-217
32. Schnabel R., Lackner K.J., Rupprecht H.J., Espinola-Klein C., Torzewski M., Lubos E., et al. Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study. J Am Coll Cardiol 45 (2005) 1631-1637
33. Sowell A.L., Huff D.L., Yeager P.R., Caudill S.P., and Gunter E.W. Retinol, alpha-tocopherol, lutein/zeaxanthin, beta-cryptoxanthin, lycopene, alpha-carotene, trans-beta-carotene, and four retinyl esters in serum determined simultaneously by reversed-phase HPLC with multiwavelength detection. Clin Chem 40 (1994) 411-416
34. Lagendijk J., Ubbink J.B., and Vermaak W.J. Measurement of the ratio between the reduced and oxidized forms of coenzyme Q10 in human plasma as a possible marker of oxidative stress. J Lipid Res 37 (1996) 67-75
35. Kingman A., Albertini T., and Brown L.J. Mercury concentrations in urine and whole blood associated with amalgam exposure in a US military population. J Dent Res 77 (1998) 461-471
36. Rhainds M., Levallois P., Dewailly E., and Ayotte P. Lead, mercury, and organochlorine compound levels in cord blood in Quebec, Canada. Arch Environ Health 54 (1999) 40-47
37. Kosatsky T., Przybysz R., and Armstrong B. Mercury exposure in Montrealers who eat St. Lawrence River sportfish. Environ Res 84 (2000) 36-43
38. Virtanen J.K., Voutilainen S., Rissanen T.H., Mursu J., Tuomainen T.P., Korhonen M.J., et al. Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in eastern Finland. Arterioscler Thromb Vasc Biol 25 (2005) 228-233
39. Perugini C., Bagnati M., Cau C., Bordone R., Paffoni P., Re R., et al. Distribution of lipid-soluble antioxidants in lipoproteins from healthy subjects. II. Effects of in vivo supplementation with alpha-tocopherol. Pharmacol Res 41 (2000) 67-74
40. Tomasetti M., Alleva R., Solenghi M.D., and Littarru G.P. Distribution of antioxidants among blood components and lipoproteins: significance of lipids/CoQ10 ratio as a possible marker of increased risk for atherosclerosis. Biofactors 9 (1999) 231-240
41. Kaikkonen J., Nyyssonen K., and Salonen J.T. Measurement and stability of plasma reduced, oxidized and total coenzyme Q10 in humans. Scand J Clin Lab Invest 59 (1999) 457-466
42. Yalcin A., Kilinc E., Sagcan A., and Kultursay H. Coenzyme Q10 concentrations in coronary artery disease. Clin Biochem 37 (2004) 706-709
43. Bliznakov E.G. From sharks to coenzyme Q10. Adv Exp Med Biol 73 (1976) 441-450
44. Murphy M.E., Kolvenbach R., Aleksis M., Hansen R., and Sies H. Antioxidant depletion in aortic crossclamping ischemia: increase of the plasma alpha-tocopheryl quinone/alpha-tocopherol ratio. Free Radic Biol Med 13 (1992) 95-100
45. Palan P.R., Woodall A.L., Anderson P.S., and Mikhail M.S. Alpha-tocopherol and alpha-tocopheryl quinone levels in cervical intraepithelial neoplasia and cervical cancer. Am J Obstet Gynecol 190 (2004) 1407-1410
46. Hasegawa G., Yamamoto Y., Zhi J.G., Tanino Y., Yamasaki M., Yano M., et al. Daily profile of plasma %CoQ10 level, a biomarker of oxidative stress, in patients with diabetes manifesting postprandial hyperglycaemia. Acta Diabetol 42 (2005) 179-181
47. Yamamoto Y., and Yamashita S. Plasma ratio of ubiquinol and ubiquinone as a marker of oxidative stress. Mol Aspects Med 18 (1997) S79-S84
48. Stocker R., Bowry V.W., and Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl Acad Sci U S A 88 (1991) 1646-1650
49. Sen C.K. Glutathione homeostasis in response to exercise training and nutritional supplements. Mol Cell Biochem 196 (1999) 31-42
50. Elosua R., Molina L., Fito M., Arquer A., Sanchez-Quesada J.L., Covas M.I., et al. Response of oxidative stress biomarkers to a 16-week aerobic physical activity program, and to acute physical activity, in healthy young men and women. Atherosclerosis 167 (2003) 327-334
51. Olmedilla B., Granado F., Blanco I., and Rojas-Hidalgo E. Seasonal and sex-related variations in six serum carotenoids, retinol, and alpha-tocopherol. Am J Clin Nutr 60 (1994) 106-110
52. Roberts W.G., Gordon M.H., and Walker A.F. Effects of enhanced consumption of fruit and vegetables on plasma antioxidant status and oxidative resistance of LDL in smokers supplemented with fish oil. Eur J Clin Nutr 57 (2003) 1303-1310
53. Blankenberg S., Rupprecht H.J., Bickel C., Torzewski M., Hafner G., Tiret L., et al. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 349 (2003) 1605-1613
54. Hulthe J., and Fagerberg B. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arterioscler Thromb Vasc Biol 22 (2002) 1162-1167
55. Mertens A., and Holvoet P. Oxidized LDL and HDL: antagonists in atherothrombosis. Faseb J 15 (2001) 2073-2084
56. Kopprasch S., Pietzsch J., Kuhlisch E., Fuecker K., Temelkova-Kurktschiev T., Hanefeld M., et al. In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance. Diabetes 51 (2002) 3102-3106
57. Aviram M., Kaplan M., Rosenblat M., and Fuhrman B. Dietary antioxidants and paraoxonases against LDL oxidation and atherosclerosis development. Handb Exp Pharmacol (2005) 263-300
58. Dugas T.R., Morel D.W., and Harrison E.H. Impact of LDL carotenoid and alpha-tocopherol content on LDL oxidation by endothelial cells in culture. J Lipid Res 39 (1998) 999-1007
59. Plante M., and Babo S. Mercury and the risk of myocardial infarction. N Engl J Med 348 (2003) 2151-2154 [author reply 2151-4]